MapLight Therapeutics, Inc.
MPLT
$16.14
$0.140.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.71M | 14.24M | 14.42M | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 97.88M | 87.20M | 82.95M | -- | -- |
| Operating Income | -97.88M | -87.20M | -82.95M | -- | -- |
| Income Before Tax | -92.43M | -80.98M | -77.58M | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -92.43 | -80.98 | -77.58 | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -92.43M | -80.98M | -77.58M | -- | -- |
| EBIT | -97.88M | -87.20M | -82.95M | -- | -- |
| EBITDA | -97.19M | -86.48M | -82.25M | -- | -- |
| EPS Basic | -121.46 | -106.65 | -105.60 | -- | -- |
| Normalized Basic EPS | -75.73 | -66.66 | -66.00 | -- | -- |
| EPS Diluted | -121.46 | -106.65 | -105.60 | -- | -- |
| Normalized Diluted EPS | -75.73 | -66.66 | -66.00 | -- | -- |
| Average Basic Shares Outstanding | 3.04M | 3.04M | 2.94M | -- | -- |
| Average Diluted Shares Outstanding | 3.04M | 3.04M | 2.94M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |